首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷 CT/MRI/X光

市場調查報告書

商品編碼

1995883

放射學領域人工智慧（AI）市場：策略性洞察與預測（2026-2031 年）

Artificial Intelligence (AI) in Radiology Market - Strategic Insights and Forecasts (2026-2031)

出版日期: 2026年03月02日 | 出版商:

Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

全球放射學人工智慧市場預計將從 2026 年的 39 億美元成長到 2031 年的 152 億美元，複合年成長率為 31.3%。

隨著醫療機構擴大採用先進的人工智慧技術來簡化影像診斷和工作流程，預計到2031年，全球放射學人工智慧（AI）市場將保持強勁成長。人工智慧解決方案正透過自動化影像分析、提高疾病檢測準確率和減輕放射科醫生的工作量，改變放射學生態系統。慢性病發病率的上升和人口老化導致醫學影像檢查的普及，進一步推動了對人工智慧放射學工具的需求。此外，深度學習和機器學習技術的進步也催生了能夠提供更快、更可靠的診斷資訊的先進應用。不斷上漲的醫療成本、對更高診斷準確率的需求以及對數位化醫療的支持，都將推動放射學人工智慧市場在預測期內持續成長。

市場促進因素

市場成長的主要驅動力之一是對更高診斷精度和更快影像解讀速度日益成長的需求。人工智慧演算法能夠檢測複雜影像資料中人眼難以辨識的細微模式和異常情況，進而提高疾病的早期發現率和治療方案的製定效率。這在腫瘤學和神經病學等領域尤其重要，因為在這些領域，及時準確地解讀X光影像至關重要。

此外，醫療機構正在採用人工智慧來應對人員短缺和診斷影像量不斷增加等挑戰。特別是放射科，由於病患需求上升、專家短缺以及診斷程序的複雜性，正面臨日益繁重的工作量。能夠自動化日常任務並支援診斷工作流程的人工智慧工具可以縮短檢測結果的返回時間，並有助於提高整體營運效率。

機器學習、深度學習和電腦視覺技術的進步正在拓展人工智慧在放射學領域的應用能力。這些技術能夠實現更高階的影像分析、分割和預測分析，從而獲得更準確、更一致的結果。領先供應商的持續創新以及與醫療機構的合作正在加速人工智慧解決方案在臨床環境中的應用。

市場限制因素

儘管預計放射學領域的AI市場將保持強勁成長，但它也面臨著資料隱私、監管合規性和整合複雜性等方面的挑戰。醫療資料高度敏感，而嚴格的病患資訊管理法規要求AI部署必須採取嚴格的安全措施。確保符合不同地區的法規結構會增加實施的複雜性和成本。

將人工智慧解決方案整合到現有的醫院資訊系統（例如影像歸檔和通訊系統 (PACS) 和放射科資訊系統 (RIS)）中，面臨著許多技術挑戰。傳統基礎設施和互通性問題會減緩新技術的採用，尤其是在資源有限的臨床環境中。

另一個限制因素是缺乏高品質、標註的醫學影像資料集，而這些資料集對於訓練和檢驗人工智慧模型至關重要。資料標準的差異以及獲取多樣化資料集的途徑有限，都會影響模型的效能和臨床接受度。解決這些數據相關的挑戰對於確保人工智慧輸出的可靠性以及增強臨床醫生的信心至關重要。

對技術和細分市場的洞察

放射學領域的人工智慧市場涵蓋多種技術領域，包括電腦輔助檢測、自動分割、自然語言處理和定量影像分析。電腦輔助檢測廣泛應用於輔助影像診斷，而新興技術正在推動進一步的自動化和進階決策支援。

應用領域包括乳房X光攝影、乳房攝影篩檢影像、神經病學和心血管影像。人工智慧在這些應用領域被廣泛應用於影像分析和風險評估，幫助臨床醫生對大量影像檢查進行優先排序和解讀。最終用戶包括醫院、影像中心和研究機構，其中醫院由於檢查量大、診斷需求高，佔據了較大的市場佔有率。

競爭格局與策略展望

競爭格局包括眾多科技公司和專業人工智慧解決方案供應商，它們提供針對放射學需求量身定做的平台和服務。主要參與者包括微軟、亞馬遜網路服務 (AWS)、IBM、Rad AI 和 Behold.ai。這些公司專注於產品創新、策略夥伴關係以及將人工智慧功能整合到更廣泛的醫療保健 IT 生態系統中，以擴大市場佔有率。

策略性市場措施包括增強人工智慧在臨床決策支援方面的能力、擴大地理覆蓋範圍，以及與醫療機構合作開發客製化解決方案。供應商也正在投資檢驗研究和監管核准，以提高臨床可信度並促進更廣泛的應用。

重點

到2031年，放射學領域的人工智慧市場將保持強勁成長勢頭，這主要得益於對更先進的診斷能力、營運效率和創新人工智慧技術日益成長的需求。儘管資料管治和整合方面仍存在挑戰，但人工智慧在改善放射學工作流程和患者預後方面的策略價值將繼續推動市場成長。

本報告的主要益處

深入分析：獲得跨地區、客戶群、政策、社會經濟因素、消費者偏好和產業領域的詳細市場洞察。
競爭格局：了解主要企業的策略趨勢，並確定最佳的市場進入方式。
市場促進因素與未來趨勢：我們評估影響市場的關鍵成長要素和新興趨勢。
實用建議：我們支援制定策略決策以開發新的收入來源。
適合各類讀者：非常適合Start-Ups、研究機構、顧問公司、中小企業和大型企業。

我們的報告的使用範例

產業和市場洞察、機會評估、產品需求預測、打入市場策略、區域擴張、資本投資決策、監管分析、新產品開發和競爭情報。

報告範圍

2021年至2025年的歷史數據和2026年至2031年的預測數據
成長機會、挑戰、供應鏈前景、法律規範與趨勢分析
競爭定位、策略和市場佔有率評估
細分市場和區域銷售成長及預測評估
公司簡介，包括策略、產品、財務狀況和主要發展動態。

北美洲
- 透過技術
- 透過使用
- 最終用戶
- 國家
  - 美國
  - 加拿大
  - 墨西哥
南美洲
- 透過技術
- 透過使用
- 最終用戶
- 國家
  - 巴西
  - 阿根廷
  - 其他
歐洲
- 透過技術
- 透過使用
- 最終用戶
- 國家
  - 德國
  - 法國
  - 英國
  - 西班牙
  - 其他
中東和非洲
- 透過技術
- 透過使用
- 最終用戶
- 國家
  - 沙烏地阿拉伯
  - UAE
  - 以色列
  - 其他
亞太地區
- 透過技術
- 透過使用
- 最終用戶
- 國家
  - 中國
  - 日本
  - 印度
  - 韓國
  - 台灣
  - 印尼
  - 其他

第9章：競爭環境與分析

主要企業及策略分析
市佔率分析
合併、收購、協議和合作關係
競爭環境儀錶板

第10章：公司簡介

Microsoft Corporation
Amazon Web Services Inc.
IBM Corporation
Rad AI
Behold.ai
IMAGEN
Aidoc
Koninklijke Philips NV
GE Healthcare
Siemens Healthcare GmbH

簡介目錄

Product Code: KSI061614385

The global AI in Radiology market is forecast to grow at a CAGR of 31.3%, reaching USD 15.2 billion in 2031 from USD 3.9 billion in 2026.

The global artificial intelligence (AI) in Radiology market is poised for strong growth through 2031 as healthcare providers increasingly adopt advanced AI technologies to enhance imaging diagnostics and workflow efficiency. AI solutions are transforming the radiology ecosystem by automating image analysis, improving disease detection accuracy, and reducing interpretive workloads for radiologists. The expansion of medical imaging procedures driven by rising incidences of chronic diseases and ageing populations further supports demand for AI-enabled radiology tools. Moreover, technological advancements in deep learning and machine learning are enabling more sophisticated applications that deliver faster and more reliable diagnostic insights. The confluence of rising healthcare expenditure, the need for enhanced diagnostic precision, and supportive digital health initiatives positions the AI in Radiology market for sustained expansion over the forecast period.

Market Drivers

One of the primary drivers of market growth is the increasing demand for improved diagnostic accuracy and faster image interpretation. AI algorithms can detect subtle patterns and anomalies in complex imaging data that may be difficult for the human eye to discern, thus enhancing early disease detection and treatment planning. This is particularly relevant in areas such as oncology and neurology where timely and precise interpretation of radiographic images is critical.

Healthcare providers are also adopting AI to address workforce challenges and rising imaging volumes. Radiology departments face workload pressures due to growing patient demand, limited specialist availability, and the complexity of diagnostic procedures. AI-enabled tools that automate routine tasks and support diagnostic workflows can help reduce turnaround times and improve overall operational efficiency.

Technological advancements in machine learning, deep learning, and computer vision are expanding the capabilities of AI applications in radiology. These technologies facilitate sophisticated image analysis, segmentation, and predictive analytics, enabling more accurate and consistent outputs. Continuous innovation by key technology vendors and partnerships with healthcare organisations are accelerating adoption of AI solutions across clinical environments.

Market Restraints

Despite robust growth prospects, the AI in Radiology market faces challenges related to data privacy, regulatory compliance, and integration complexity. Healthcare data is highly sensitive, and stringent regulations governing patient information require rigorous safeguards for AI implementations. Ensuring compliance with varying regulatory frameworks across regions can increase deployment complexity and cost.

Integration of AI solutions with existing hospital information systems, such as picture archiving and communication systems (PACS) and radiology information systems (RIS), can be technically challenging. Legacy infrastructure and interoperability issues may slow the adoption of new technologies, particularly in resource-constrained clinical settings.

Another restraint is the need for high-quality, annotated medical imaging datasets to train and validate AI models. Variability in data standards and limited access to diverse datasets can impact model performance and clinical acceptance. Addressing these data challenges is essential to ensure reliable AI outputs and build clinician trust.

Technology and Segment Insights

The AI in Radiology market encompasses various technology segments, including computer-aided detection, auto-segmentation, natural language processing, and quantitative imaging analytics. Computer-aided detection is widely used to support image interpretation, while emerging technologies enable enhanced automation and decision support.

Application segments include mammography, chest imaging, neurology, cardiovascular imaging, and others. AI is extensively used for image analysis and risk assessment across these applications, helping clinicians to prioritise and interpret high volumes of imaging studies. End-users include hospitals, diagnostic imaging centres, and research institutions, with hospitals accounting for a significant share due to high procedural volumes and diagnostic demand.

Competitive and Strategic Outlook

The competitive landscape comprises technology companies and specialised AI solution providers that offer platforms and services tailored to radiology needs. Key players include Microsoft Corporation, Amazon Web Services, IBM Corporation, Rad AI, and Behold.ai, among others. These firms focus on product innovation, strategic partnerships, and integration of AI capabilities into broader healthcare IT ecosystems to expand market reach.

Strategic initiatives in the market include enhancing AI functionalities for clinical decision support, expanding geographic presence, and collaborating with healthcare institutions to co-develop tailored solutions. Vendors are also investing in validation studies and regulatory approvals to strengthen clinical credibility and facilitate wider adoption.

Key Takeaways

The AI in Radiology market is on a strong growth trajectory through 2031, driven by rising demand for improved diagnostic capabilities, operational efficiencies, and innovative AI technologies. While data governance and integration challenges persist, the strategic value of AI in enhancing radiology workflows and patient outcomes will continue to propel market growth.

Key Benefits of this Report

Insightful Analysis: Gain detailed market insights across regions, customer segments, policies, socio-economic factors, consumer preferences, and industry verticals.
Competitive Landscape: Understand strategic moves by key players to identify optimal market entry approaches.
Market Drivers and Future Trends: Assess major growth forces and emerging developments shaping the market.
Actionable Recommendations: Support strategic decisions to unlock new revenue streams.
Caters to a Wide Audience: Suitable for startups, research institutions, consultants, SMEs, and large enterprises.

What businesses use our reports for

Industry and market insights, opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment decisions, regulatory analysis, new product development, and competitive intelligence.

Report Coverage

Historical data from 2021 to 2025 and forecast data from 2026 to 2031
Growth opportunities, challenges, supply chain outlook, regulatory framework, and trend analysis
Competitive positioning, strategies, and market share evaluation
Revenue growth and forecast assessment across segments and regions
Company profiling including strategies, products, financials, and key developments

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits for the Stakeholders

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Research Process

3. EXECUTIVE SUMMARY

3.1. Key Findings

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View

5. AI IN RADIOLOGY MARKET BY TECHNOLOGY

5.1. Introduction
5.2. Computer-aided Detection
5.3. Auto-segmentation of Organs
5.4. Natural Language Processing
5.5. Consultation
5.6. Quantification and Kinetics
5.7. Others

6. AI IN RADIOLOGY MARKET BY APPLICATION

6.1. Introduction
6.2. Mammography
6.3. Chest Imaging
6.4. Neurology
6.5. Cardiovascular
6.6. Others

7. AI IN RADIOLOGY MARKET BY END-USER

7.1. Introduction
7.2. Hospitals
7.3. Diagnostic Imaging Centers
7.4. Others

8. AI IN RADIOLOGY MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. By Technology
- 8.2.2. By Application
- 8.2.3. By End-User
- 8.2.4. By Country
  - 8.2.4.1. USA
  - 8.2.4.2. Canada
  - 8.2.4.3. Mexico
8.3. South America
- 8.3.1. By Technology
- 8.3.2. By Application
- 8.3.3. By End-User
- 8.3.4. By Country
  - 8.3.4.1. Brazil
  - 8.3.4.2. Argentina
  - 8.3.4.3. Others
8.4. Europe
- 8.4.1. By Technology
- 8.4.2. By Application
- 8.4.3. By End-User
- 8.4.4. By Country
  - 8.4.4.1. Germany
  - 8.4.4.2. France
  - 8.4.4.3. United Kingdom
  - 8.4.4.4. Spain
  - 8.4.4.5. Others
8.5. Middle East and Africa
- 8.5.1. By Technology
- 8.5.2. By Application
- 8.5.3. By End-User
- 8.5.4. By Country
  - 8.5.4.1. Saudi Arabia
  - 8.5.4.2. UAE
  - 8.5.4.3. Israel
  - 8.5.4.4. Others
8.6. Asia Pacific
- 8.6.1. By Technology
- 8.6.2. By Application
- 8.6.3. By End-User
- 8.6.4. By Country
  - 8.6.4.1. China
  - 8.6.4.2. Japan
  - 8.6.4.3. India
  - 8.6.4.4. South Korea
  - 8.6.4.5. Taiwan
  - 8.6.4.6. Indonesia
  - 8.6.4.7. Others